Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study-Reference-Cited by-同舟云学术

Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study

Published:2021-12 Issue: Volume:Volume 8 Page:1565-1577
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Kim Minseok Albert^ORCID,Jang Heejoon^ORCID,Choi Na Ryung,Nam Joon Yeul,Lee Yun Bin,Cho Eun Ju^ORCID,Lee Jeong-Hoon^ORCID,Yu Su Jong,Kim Hyo-Cheol^ORCID,Chung Jin Wook^ORCID,Yoon Jung-Hwan,Kim Yoon Jun^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference45 articles.

1. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

2. Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

3. Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation

4. Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence-Based Analysis

5. A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Considerations When Choosing Chemoembolization versus Radioembolization for Hepatocellular Carcinoma;Seminars in Interventional Radiology;2024-02

2. Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts;Cancers;2024-01-04

3. Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes;Journal of Liver Cancer;2023-09-30

4. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis;Journal of Medical Economics;2023-08-26

5. Transarterial chemoembolization versus radioembolization as a treatment option for single large (>5 cm) hepatocellular carcinoma: a retrospective study in South Korea;Life Cycle;2023-08-25